InsiderClue
Insiders · Profile

Dier Mardi

EVP and CFO at MADRIGAL PHARMACEUTICALS · CFO & Executive Vice President at Ultragenyx Pharmaceutical · Director at Prelude Therapeutics. Filing since 29 Sep 2020. CIK 0001574591

MDGL MADRIGAL PHARMACEUTICALS, INC. EVP and CFO · 5 trades RARE Ultragenyx Pharmaceutical Inc. CFO & Executive Vice President · 6 trades PRLD Prelude Therapeutics Inc Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
MDGL MADRIGAL PHARMACEUTICALS, INC.
6 Mar 2026
EVP and CFO
Sold on a plan
1,982
$853.99K
13.7%
MDGL MADRIGAL PHARMACEUTICALS, INC.
2 Mar 2026
EVP and CFO
Sold at will
1,183
$505.39K
11.3%
MDGL MADRIGAL PHARMACEUTICALS, INC.
2 Dec 2025
EVP and CFO
Sold on a plan
4,173
$2.41M
28.6%
MDGL MADRIGAL PHARMACEUTICALS, INC.
10 Mar 2025
SVP and CFO
Sold on a plan
258
$83.34K
2.4%
MDGL MADRIGAL PHARMACEUTICALS, INC.
3 Mar 2025
SVP and CFO
Sold on a plan
1,961
$637.25K
22.1%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2022
CFO & Executive Vice President
Sold, plan not stated
1,629
$65.42K
2.4%
RARE Ultragenyx Pharmaceutical Inc.
12 Oct 2022
CFO & Executive Vice President
Sold, plan not stated
3,484
$133.16K
4.9%
RARE Ultragenyx Pharmaceutical Inc.
3 Mar 2022
CFO & Executive Vice President
Sold, plan not stated
420
$27.11K
0.8%
RARE Ultragenyx Pharmaceutical Inc.
1 Mar 2022
CFO & Executive Vice President
Sold, plan not stated
534
$35.58K
1.4%
RARE Ultragenyx Pharmaceutical Inc.
14 Oct 2021
CFO & Executive Vice President
Sold, plan not stated
3,261
$264.66K
7.8%
RARE Ultragenyx Pharmaceutical Inc.
12 Oct 2021
CFO & Executive Vice President
Sold, plan not stated
3,477
$287.86K
7.6%
PRLD Prelude Therapeutics Inc
29 Sep 2020
Director
Bought
10,000
$190.00K
opened
12 decisions on file.